Regional comparison of efficacy and safety for vilobelimab in critically ill, invasively mechanically ventilated COVID-19 patients by Gernot Marx, Antoine Roquilly, Tobias Welte, Jean Dellamonica, Greet Hermans, Martin Witzenrath, Michael Bauer, Matthias Gründling, Ulrich Jaschinski, Robert Zerbib, Djillali Annane, Matthijs C Brouwer, Bruno Mourvillier, Jean Baptiste Lascarrou, Francis Schneider, Guillaume Thiéry, Diederik van de Beek, Carole Schwebel, Fabio S. Taccone, Luc Desmedt, Claire Dupuis, Pieter van Paassen, Michael Piagnerelli, Endry H T Lim, Sanne de Bruin, Simon Rückinger, Claus Thielert, Renfeng Guo, Bruce P Burnett, Camilla Chong, Niels C Riedemann, Alexander P Vlaar, Alexander P. J. Vlaar, Leo M. A. Heunks, Sanne de Bruin, Endry H. T. Lim, Matthijs C. Brouwer, Pieter R. Tuinman, José Francisco K. Saraiva, Suzana M. Lobo, Rodrigo Boldo, Jesus A. Simon-Campos, Alexander D. Cornet, Anastasia Grebenyuk, Johannes M. Engelbrecht, Murimisi Mukansi, Philippe G. Jorens, Korinna Pilz, Diederik van de Beek, Niels C. Riedemann, Pierre Bulpa, Marc Diltoer, Nikolaas De Neve, Antonio T. Freire, Felipe D. Pizzol, Anna Karolina Marinho, Victor H. Sato, Clovis Arns da Cunha, Mathilde Neuville, Jean Luc Diehl, Jean Paul Mira, Marc Berger, Klaus Matschke, Roberto Mercado-Longoria, Belinda Gomez Quintana, Jorge Alberto Zamudio-Lerma

Get full text